2-178718467-T-G
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 1P and 2B. PP2BP4_Moderate
The NM_001267550.2(TTN):āc.24639A>Cā(p.Gln8213His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000106 in 1,613,608 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001267550.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTN | NM_001267550.2 | c.24639A>C | p.Gln8213His | missense_variant | 85/363 | ENST00000589042.5 | NP_001254479.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TTN | ENST00000589042.5 | c.24639A>C | p.Gln8213His | missense_variant | 85/363 | 5 | NM_001267550.2 | ENSP00000467141.1 |
Frequencies
GnomAD3 genomes AF: 0.0000855 AC: 13AN: 152118Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000282 AC: 7AN: 248386Hom.: 0 AF XY: 0.0000297 AC XY: 4AN XY: 134740
GnomAD4 exome AF: 0.000108 AC: 158AN: 1461490Hom.: 0 Cov.: 35 AF XY: 0.000100 AC XY: 73AN XY: 727022
GnomAD4 genome AF: 0.0000855 AC: 13AN: 152118Hom.: 0 Cov.: 33 AF XY: 0.0000942 AC XY: 7AN XY: 74302
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 07, 2020 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2022 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Aug 02, 2023 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Sep 01, 2012 | Variant classified as Uncertain Significance - Favor Benign. The Gln6969His vari ant in TTN has not been reported in the literature nor previously identified by our laboratory. Glutamine (Gln) at position 6969 is not well conserved in evolut ion and 2 mammals (pika and shrew) carry a histidine (His; this variant), suppor ting that this change may be tolerated. Other computational analyses (biochemica l amino acid properties, AlignGVGD, and PolyPhen2) also suggest that this varian t may not impact the protein, though this information is not predictive enough t o rule out pathogenicity. In summary, additional information is needed to fully assess the clinical significance of the Gln6969His variant. - |
Autosomal recessive limb-girdle muscular dystrophy type 2J;C1858763:Dilated cardiomyopathy 1G Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 10, 2017 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at